The gene dosage hypothesis is supported by the finding of decreased PMP22 protein[71] and decreased PMP22 mRNA expression levels in HNPP patients[173] that correlated with phenotype[174]. Here, PMP22 is linked to hereditary neuropathy with liability to pressure palsies.